Ji Li is the founder of AffaMed Therapeutics. AffaMed Therapeutics has raised $170M in total funding. Latest round: Series B. Based in Shanghai, China.
Ji Li is associated with AffaMed Therapeutics, a cross-border clinical-stage biopharmaceutical company focused on ophthalmic and neuroscience programs. BioCentury described him as one of China’s most prominent dealmakers in connection with AffaMed’s development efforts and financing activity.
Full founder directory · Investor directory · Company funding database · Fundraising library